Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

All Pregnant Women In Thailand May Soon Get Zika Test

XTALKS VITALS NEWS

Pregnancy

Last week, the country confirmed its first known case of microcephaly, a birth defect that has been associated with Zika infection during pregnancy.

Tweetables from this article:

Tweet: #Zika tests which cost approximately $58 would be offered free-of-charge to all pregnant women in #Thailand http://ctt.ec/8O80e+ Zika tests which cost approximately $58 would be offered free-of-charge to all pregnant women in Thailand.

Share this!

October 4, 2016 | by Sarah Hand, M.Sc.

According to Thailand’s health ministry, the country is considering implementing country-wide Zika virus testing for all pregnant women. Last week, the country confirmed its first known case of microcephaly, a birth defect that has been associated with Zika infection during pregnancy.

Two cases of Zika-associated microcephaly have now been confirmed, which are the first of their kind in Southeast Asia. The Zika virus – spread by the Aedes aegypti mosquito – has begun to spread in the area since the first cases were confirmed in the Americas last year.

“The health minister has asked us to study whether this is necessary and cost-effective,” Sophon Mekthon, health minister permanent secretary told Reuters. The tests – which cost approximately 2,000 baht ($58) – would be offered free-of-charge, however Mekthon says that the diagnostic test must often be repeated to confirm results.



“At the moment, we check pregnant women in Zika-affected areas only, not all pregnant women,” said Mekthon. “So far, we've tested about 1,000 pregnant women.”

Microcephaly is one of the birth defects caused by the Zika virus, with small head size potentially leading to brain damage and other problems. Brazil is considered to be the epicenter of the current Zika outbreak, with over 1,800 cases of microcephaly confirmed to date.

Other Southeast Asian countries including Thailand and Singapore have identified nearly 400 cases of the Zika virus, with some of these occurring in pregnant women. With no available vaccine and up to 80 percent of cases being asymptomatic, those who are infected are often unaware.

In Singapore, Zika testing is free for expectant mothers showing symptoms of the disease, or those with a male partner who is infected. Some cases of sexual transmission of the disease have been reported, and the Zika virus has been linked to a rare neurological condition called Guillain-Barre syndrome in adults.


Keywords: Zika Virus, Diagnostic Test, Pregnancy


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News


Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News


Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.